المؤلفون: De Cock, D., Corluy, L., Joos, R., Langenaken, C., Taelman, V., Raeman, F., Ravilingien, I., Vandevyvere, K., Lenaerts, J., Geens, E., Geusens, P., Vanhoof, J., Durnez, A., Remans, J., Vander Cruyssen, B., Van Essche, E., Sileghem, A., De Brabanter, G., Joly, J., Meyfroidt, S., Van der Elst, K., Westhovens, R., Verschueren, P.

المصدر: Annals of the Rheumatic Diseases ; volume 74, page 236-237 ; ISSN 0003-4967

الاتاحة: https://doi.org/10.1136/annrheumdis-2015-eular.3984
https://api.elsevier.com/content/article/PII:S0003496724532964?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0003496724532964?httpAccept=text/plain
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2015-eular.3984

المؤلفون: Verschueren, P., de Cock, D., Corluy, L., Joos, R., Langenaken, C., Taelman, V., Raeman, F., Ravelingien, I., Vandevyvere, K., Lenaerts, J., Geens, E., Geusens, P., Vanhoof, J., Durnez, A., Remans, J., vander Cruyssen, B., van Essche, E., Sileghem, A., de Brabanter, G., Joly, J., Meyfroidt, S., van der Elst, K., Westhovens, R.

المصدر: Verschueren , P , de Cock , D , Corluy , L , Joos , R , Langenaken , C , Taelman , V , Raeman , F , Ravelingien , I , Vandevyvere , K , Lenaerts , J , Geens , E , Geusens , P , Vanhoof , J , Durnez , A , Remans , J , vander Cruyssen , B , van Essche , E , Sileghem , A , de Brabanter , G , Joly , J , Meyfroidt , S , van der Elst , K & Westhovens , R 2015 , ....

مصطلحات موضوعية: MODIFYING ANTIRHEUMATIC DRUGS, PLACEBO-CONTROLLED TRIAL, EARLY RA PATIENTS, DOUBLE-BLIND, RANDOMIZED-TRIAL, TIGHT CONTROL, RADIOGRAPHIC PROGRESSION, TREATMENT STRATEGIES, TARGET STRATEGY, BIOLOGIC AGENTS

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/f1551480-3c42-4c48-beb4-5486cd35f754
https://doi.org/10.1136/annrheumdis-2014-205489

المؤلفون: Verschueren, P., de Cock, D., Corluy, L., Joos, R., Langenaken, C., Taelman, V., Raeman, F., Ravelingien, I., Vandevyvere, K., Lenaerts, J., Geens, E., Geusens, P., Vanhoof, J., Durnez, A., Remans, J., vander Cruyssen, B., van Essche, E., Sileghem, A., de Brabanter, G., Joly, J., van der Elst, K., Meyfroidt, S., Westhovens, R., CareRA study group, the

المصدر: Verschueren , P , de Cock , D , Corluy , L , Joos , R , Langenaken , C , Taelman , V , Raeman , F , Ravelingien , I , Vandevyvere , K , Lenaerts , J , Geens , E , Geusens , P , Vanhoof , J , Durnez , A , Remans , J , vander Cruyssen , B , van Essche , E , Sileghem , A , de Brabanter , G , Joly , J , van der Elst , K , Meyfroidt , S , Westhovens , R & CareRA ....

مصطلحات موضوعية: COMBINATION-TREATMENT STRATEGIES, MODIFYING ANTIRHEUMATIC DRUGS, TIGHT CONTROL, EULAR RECOMMENDATIONS, AMERICAN-COLLEGE, FOLLOW-UP, MANAGEMENT, THERAPY, REMISSION, CLASSIFICATION

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/dcf0027d-9acc-452e-899e-b161d6254b6e
https://doi.org/10.1186/s13075-015-0611-8

المؤلفون: Stouten, Veerle, Westhovens, Rene, Pazmino, Sofia, De Cock, Diederik, Van der Elst, Kristien, Joly, Johan, Verschueren, Patrick, Maeyaert, B, De Brabanter, G, Devinck, M, Langenaken, C, Lenaerts, J, Corluy, L, Remans, J, Vander Cruyssen, B, Ravelingien, I, Van Essche, E, Vandevyvere, K, Durnez, A, Verbruggen, A, Geens, E, Raeman, F, Joos, R, de Vlam, K, Taelman, V, Vanhoof, J, Coppens, M, Geusens, P, Sileghem, A, Volders, P, Van Den Bosch, F, Verschueren, P, Westhovens, R

المساهمون: Public Health Sciences

المصدر: Rheumatology. 58:2284-2294

مصطلحات موضوعية: Male, Time Factors, early rheumatoid arthritis, Severity of Illness Index, OPPORTUNITY, WINDOW, law.invention, Arthritis, Rheumatoid, Prednisone/administration & dosage, Antirheumatic Agents/administration & dosage, Joints/diagnostic imaging, Randomized controlled trial, law, Prednisone, Pharmacology (medical), Prospective Studies, Leflunomide, treatment, glucocorticoids, TREATMENT STRATEGIES, Middle Aged, Prognosis, OPEN-LABEL, Treatment Outcome, TARGET, Antirheumatic Agents, Rheumatoid arthritis, Arthritis, Rheumatoid/diagnosis, Prednisolone, Drug Therapy, Combination, Female, TRIAL, DMARDs (synthetic), Life Sciences & Biomedicine, Immunosuppressive Agents, medicine.drug, medicine.medical_specialty, REMISSION INDUCTION, effectiveness, Leflunomide/administration & dosage, PREDNISOLONE, Drug Administration Schedule, methotrexate, Sulfasalazine/administration & dosage, Rheumatology, Sulfasalazine, Internal medicine, medicine, Humans, Adverse effect, Immunosuppressive Agents/administration & dosage, Glucocorticoids, Science & Technology, Dose-Response Relationship, Drug, business.industry, Glucocorticoids/administration & dosage, medicine.disease, Radiography, Regimen, Joints, business, Follow-Up Studies

وصف الملف: Print

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96a225fecd519bcc0ec38ed9b878adf4
https://doi.org/10.1093/rheumatology/kez213

المؤلفون: Verschueren, P., De Cock, D., Corluy, L., Joos, R., Langenaken, C., Taelman, V., Raeman, F., Ravelingien, I., Vandevyvere, K., Lenaerts, J., Geens, E., Geusens, P., Vanhoof, J., Durnez, A., Remans, J., Vander Cruyssen, B., Van Essche, E., Sileghem, A., De Brabanter, G., Joly, J., Meyfroidt, S., Van der Elst, K., Westhovens, R.

المصدر: Annals of the Rheumatic Diseases ; volume 73, page 226 ; ISSN 0003-4967

الاتاحة: https://doi.org/10.1136/annrheumdis-2014-eular.2137
https://api.elsevier.com/content/article/PII:S0003496724606412?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0003496724606412?httpAccept=text/plain
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2014-eular.2137

المؤلفون: Verhelst, D, Nachtergaele, M, Hindryckx, C, Vandevyvere, K, Seghers, S, Smessaert, K, Vanderschueren, S

المصدر: International Journal of Care Pathways ; volume 15, issue 4, page 115-118 ; ISSN 2040-4034

الاتاحة: https://doi.org/10.1258/jicp.2011.011024
https://journals.sagepub.com/doi/pdf/10.1258/jicp.2011.011024
https://journals.sagepub.com/doi/full-xml/10.1258/jicp.2011.011024

المؤلفون: Verschueren, P., De Cock, D., Corluy, L., Joos, R., Langenaken, C., Taelman, V., Raeman, F., Ravilingien, I., Vandevyvere, K., Lenaerts, J., Geens, E., Geusens, P., Vanhoof, J., Durnez, A., Remans, J., Vander Cruyssen, B., Van Essche, E., Sileghem, A., De Brabanter, G., Joly, J., Van der Elst, K., Meyfroidt, S., Westhovens, R.

المصدر: Annals of the Rheumatic Diseases ; volume 74, issue Suppl 2, page 139.2-139 ; ISSN 0003-4967 1468-2060

الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2015-eular.4018
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2015-eular.4018

المؤلفون: De Cock, D., Westhovens, R., Corluy, L., Joos, R., Langenaken, C., Taelman, V., Raeman, F., Ravelingien, I., Vandevyvere, K., Lenaerts, J., Geens, E., Geusens, P., Vanhoof, J., Durnez, A., Remans, J., Vander Cruyssen, B., Van Essche, E., Sileghem, A., De Brabanter, G., Joly, J., Meyfroidt, S., Van der Elst, K., Verschueren, P.

المصدر: Annals of the Rheumatic Diseases ; volume 73, issue Suppl 2, page 220.1-220 ; ISSN 0003-4967 1468-2060

الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2014-eular.2144
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2014-eular.2144

المؤلفون: Vandevyvere, K., Luyten, F. P., Verschueren, P., Lories, R., Segaert, S., Westhovens, R.

المصدر: Clinical Rheumatology ; volume 26, issue 12, page 2205-2206 ; ISSN 0770-3198 1434-9949

الاتاحة: http://dx.doi.org/10.1007/s10067-007-0733-8
http://link.springer.com/content/pdf/10.1007/s10067-007-0733-8.pdf
http://link.springer.com/article/10.1007/s10067-007-0733-8/fulltext.html
http://link.springer.com/content/pdf/10.1007/s10067-007-0733-8

المؤلفون: Verschueren, P, De Cock, D, Corluy, L, Joos, R, Langenaken, C, Taelman, V, Raeman, F, Ravelingien, I, Vandevyvere, K, Lenaerts, J, Geens, E, Geusens, P, Vanhoof, J, Durnez, A, Remans, J, Vander Cruyssen, B, Van Essche, E, Sileghem, A, De Brabanter, G, Joly, J

المصدر: Annals of the Rheumatic Diseases; Jan2015, Vol. 74 Issue 1, p27-34, 8p

مصطلحات موضوعية: THERAPEUTIC use of glucocorticoids, RHEUMATOID arthritis diagnosis, COMBINATION drug therapy, HETEROCYCLIC compounds, ANTIRHEUMATIC agents, METHOTREXATE, RISK assessment, SEVERITY of illness index, TREATMENT effectiveness, RHEUMATOID arthritis, QUESTIONNAIRES, PREDNISONE, SULFONAMIDES, EARLY medical intervention